Albert Esquirol

20PUBLICATIONS
99CO-AUTHORS
Respiratory diseasesHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Oct 28, 2026
HCT-FS-Defined Frailty Is Associated With Lower Survival Across Diverse Hematologic Diagnoses After Allogeneic Transplantation.

|Oct 14, 2026
Association Between the Time of Day of Post-Transplant Cyclophosphamide Administration and Haemorrhagic Cystitis After Allogeneic Haematopoietic Stem Cell Transplantation.

|Aug 12, 2025
Frailty dynamics and their impact on QoL in patients undergoing autologous HCT for multiple myeloma: Results from a multicentre GETH-TC study.

Carles Tolosa-Ridao, Mónica Baile González, Marina Acera Gómez

|Feb 05, 2025
The impact of individual comorbidities in transplant recipients receiving post-transplant cyclophosphamide.

Alexandros Spyridonidis, Myriam Labopin, Bipin P Savani

|Jan 22, 2025
HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma.

Ana Carolina Caballero, Cristina Ujaldón-Miró, Paula Pujol-Fernández

|Nov 15, 2024
Development and Clinical Validation of Liquid Chromatography-Tandem Mass Spectrometry for Measuring Ruxolitinib in Steroid-Refractory Graft-Versus-Host Disease: A First Step Towards Optimized Treatment.

Sara Redondo, María Costa, Maria-Estela Moreno-Martinez

Pageof 4

Frequent Collaborators

10 joint publications

Irene García-Cadenas

7 joint publications

Rodrigo Martino

4 joint publications

María Laura Fox

4 joint publications

Sara Redondo